Uncategorised - European Medical Journal

Dasatinib Enhances Immune Activation in Philadelphia Leukaemia

Dasatinib plus blinatumomab demonstrated greater and sustained immune activation than ponatinib combinations in Ph+ acute lymphoblastic leukaemia, with marked effects on lymphocytes and natural killer cells.

Lactate Clearance Helps Predict Massive Transfusion in GI Bleeding

New real-world data suggest early lactate clearance can predict massive transfusion needs in upper gastrointestinal bleeding, improving early risk stratification when combined with the Glasgow-Blatchford score.

Older adult undergoing respiratory assessment, idiopathic pulmonary fibrosis, ACE inhibitor use and mortality outcomes

ACE Inhibitor Use Linked to Lower IPF Mortality

In idiopathic pulmonary fibrosis, ACE inhibitor use was associated with lower all-cause mortality in propensity matched EHR cohorts.

Nursery Life Reshapes the Infant Microbiome

Babies rapidly share gut microbes at nursery, with peer contact shaping the infant microbiome as strongly as family by the first year of life.

hidradenitis suppurativa patient-reported outcome measures questionnaire assessing quality of life and symptoms

Hidradenitis Suppurativa Patient-Reported Outcome Measures Reviewed

A review found seven hidradenitis suppurativa patient-reported key outcome measures, with HiSQOL-17 performing best across studies.

New Guidance Supports HPV Self-Sampling for Cervical Screening

Updated guidance supports HPV self-sampling as an effective way to increase cervical cancer screening uptake among under-screened women.

Evolving Prostate Cancer Therapy: Bertrand Tombal

Evolving Prostate Cancer Therapy: Bertrand Tombal. Chairman, Division of Urology; Full Professor of Urology, Université Catholique de Louvain, Cliniques Universitaires Saint-Luc, Brussels, Belgium…..

Explore Key Outcomes from the SEQUENCE Trial

In this podcast, listen to Laurent Peyrin-Biroulet’s insights into the latest data from the SEQUENCE trial, including implications for…

Tools, Trials, and Treatments: Navigating RCC in Real Life

In the final podcast of this three-part series, we hear expert insights into evolving guidelines, practical tools, and multidisciplinary…

NMIBC Highlights from ESMO 2025

The therapeutic landscape in non-muscle-invasive bladder cancer (NMIBC) is advancing with the investigation of new treatment…